Síntese de 1,3,4-oxadiazóis acoplados a piperazina alquilada e avaliação da ação citotóxica em modelos in vitro de linhagens de tumores animais
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
In 2020 cancer still remains one of the leading causes of death in the world.
Since the treatments and drugs used still have a low selectivity and cause various
side effects in patients, it is important to continue scientific studies to propose new
chemotherapeutic drugs that are more active and more selective that cause fewer
adverse effects. With a deficit of effective drugs, this work aimed at the synthesis and
characterization of 1,3,4-oxadiazolic derivatives coupled to alkylated piperazines and
the evaluation of their cytotoxic activities. Eight new compounds were obtained in a
five-step synthesis starting from two different carboxylic acids, which after
esterefication and hydrazinolysis of the esters made it possible to obtain hydrazides,
which after reaction with bromoacetyl bromide formed the N,N'-diacylhydrazine
intermediates that were cyclized to obtain 1,3,4-oxadiazole derivatives. These
derivatives were coupled with alkylated piperazines with chains of 8, 10, 12 and 14
carbon atoms. All synthesized compounds were characterized by 1H, 13C and IR
NMR spectra. Once the compounds were characterized, their antitumor activities
against animal tumor cell lines were evaluated by cytotoxicity to determine IC50 and
IS. All the tested compounds obtained cytotoxicity against 4T1 and CT26.WT cell
lines, where were obtained CI50 values that varied from 2.6 µM to 72.2 µM with IS
from 0.4 to 4.0 for cell line 4T1 and 2.6 µM to 35.2 µM with IS from 1.1 to 2.5 for cell
line CT26.WT. Notably, the compounds (7) and (17) synthesized in the present
project were more cytotoxic than cisplatin, the positive control used .
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

